Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure.

Nymo, Ståle H

Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure. [electronic resource] - JACC. Heart failure 04 2017 - 256-264 p. digital

Publication Type: Journal Article

2213-1787

10.1016/j.jchf.2017.01.008 doi


Biomarkers--blood
Blood Proteins
C-Reactive Protein--metabolism
Cardiovascular Diseases--mortality
Cause of Death
Chemokine CCL21--blood
Chronic Disease
Endostatins--blood
Galectin 3--blood
Galectins
Heart Failure--blood
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Inflammation
Interleukin-1 Receptor-Like 1 Protein--blood
Interleukin-8--blood
Mortality
Natriuretic Peptide, Brain--blood
Peptide Fragments--blood
Prognosis
Proportional Hazards Models
Rosuvastatin Calcium--therapeutic use
Serum Amyloid P-Component--metabolism
Troponin T--blood